These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8657505)

  • 1. [Septicemia in children treated with exchange transfusions because of hemolytic disease of the newborn].
    Kordyasz E
    Pediatr Pol; 1995 Sep; 70(9):733-7. PubMed ID: 8657505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 3. Term neonates with hemolytic disease of the newborn and necrotizing enterocolitis: a report of two cases.
    Roig JC; Burchfield DJ
    J Perinatol; 1994; 14(3):201-3. PubMed ID: 8064424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO haemolytic disease: sex ratio and blood groups in the newborns requiring treatment.
    Hodr R
    Czech Med; 1989; 12(3):125-33. PubMed ID: 2509171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 6. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in treatment of RH negative blood incompatibility of mothers and infants.
    Chinn PC; Mueller JM
    Ment Retard; 1971 Feb; 9(1):12-5. PubMed ID: 4995878
    [No Abstract]   [Full Text] [Related]  

  • 9. [Causes of regression in the exchange transfusion of newborn infants in Styria].
    Rosegger VH; Teubl I; Stern E; Müller WD; Haidvogl M
    Wien Med Wochenschr; 1978 May; 128(10):298-301. PubMed ID: 96610
    [No Abstract]   [Full Text] [Related]  

  • 10. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
    Ceccon ME; Diniz EM; Ramos JL; Vaz FA
    Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemolytic disease of the newborn from the viewpoint of the pediatrician].
    Janovský M; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):485-8. PubMed ID: 4982153
    [No Abstract]   [Full Text] [Related]  

  • 12. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Vox Sang; 2011 Apr; 100(3):312-6. PubMed ID: 20849463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. VII. Indications for exchange transfusion in Rh-incompatibility].
    Schneeweiss B
    Padiatr Grenzgeb; 1970; 9(3):208-17. PubMed ID: 4997628
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment in Rh incompatibility.
    Lozińska D
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1111-5. PubMed ID: 107912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probable graft-vs-graft reaction in an infant after exchange transfusion and marrow transplantation.
    Lauer BA; Githens JH; Hayward AR; Conrad PD; Yanagihara RT; Tubergen DG
    Pediatrics; 1982 Jul; 70(1):43-7. PubMed ID: 6806770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemoglobin level and erythrocyte count in children up to 2 years old treated by exchange transfusions because of blood incompatibility].
    Rudkowski Z; Prandota A; Czarnecka M; Bohdanowicz E
    Pediatr Pol; 1969 Dec; 44(12):1487-93. PubMed ID: 4984229
    [No Abstract]   [Full Text] [Related]  

  • 17. [Late mortality after exchange transfusion at birth].
    Baratono S; Grazia G
    Minerva Pediatr; 1972 Apr; 24(14):583-5. PubMed ID: 4623354
    [No Abstract]   [Full Text] [Related]  

  • 18. [The exchange transfusion in hemolytic disease of the newborn due to ABO-incompatibility].
    Olearczyk J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):364-5. PubMed ID: 4193015
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence of neonates treated with exchange transfusion for hemolytic disease due to ABO system incompatibility during the past 16 years].
    Hodr R; Zoban P; Hromádková L; Kepertová M; Skutilová J
    Cesk Pediatr; 1987 Aug; 42(8):464-6. PubMed ID: 3664755
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.